These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 29348863)
1. No association between Zhang A; Shi TY; Zhao Y; Xiang J; Yu D; Liang Z; Xu C; Zhang Q; Hu Y; Wang D; He J; Duan P Oncotarget; 2017 Dec; 8(68):112761-112769. PubMed ID: 29348863 [TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of associations between the TP53 Arg72Pro polymorphism with risk of head and neck carcinomas based on case-control studies. Ren WH; Jiang DK; Pei Y; Wang SQ; Yang XM; Yu L Genet Mol Res; 2014 Jan; 13(1):103-14. PubMed ID: 24446292 [TBL] [Abstract][Full Text] [Related]
3. The association between TP53 Arg72pro polymorphism and non-melanoma skin cancer risk: a meta-analysis including 7,107 subjects. Yang X; Yang B; Liu Y; Xu S; Li B Indian J Dermatol; 2013 May; 58(3):175-80. PubMed ID: 23723465 [TBL] [Abstract][Full Text] [Related]
4. TP53 Arg72Pro polymorphism and skin cancer risk: a meta-analysis. Jiang DK; Wang WZ; Ren WH; Yao L; Peng B; Yu L J Invest Dermatol; 2011 Jan; 131(1):220-8. PubMed ID: 20861852 [TBL] [Abstract][Full Text] [Related]
5. TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: a meta-analysis. Jiang DK; Yao L; Wang WZ; Peng B; Ren WH; Yang XM; Yu L World J Gastroenterol; 2011 Mar; 17(9):1227-33. PubMed ID: 21448430 [TBL] [Abstract][Full Text] [Related]
6. Meta-analysis shows significant association of the TP53 Arg72Pro with ovarian cancer risk. Shen SQ; Jiang DK; Liu GY; Chen F; Yu L Mol Biol Rep; 2012 Apr; 39(4):4683-90. PubMed ID: 21952824 [TBL] [Abstract][Full Text] [Related]
7. Association between TP53 Arg72Pro polymorphism and hepatocellular carcinoma risk: a meta-analysis. Xu CT; Zheng F; Dai X; Du JD; Liu HR; Zhao L; Li WM Asian Pac J Cancer Prev; 2012; 13(9):4305-9. PubMed ID: 23167333 [TBL] [Abstract][Full Text] [Related]
8. Pro variant of TP53 Arg72Pro contributes to esophageal squamous cell carcinoma risk: evidence from a meta-analysis. Wang B; Wang D; Zhang D; Li A; Liu D; Liu H; Jin H Eur J Cancer Prev; 2010 Jul; 19(4):299-307. PubMed ID: 20389250 [TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and bladder cancer risk. Liu ZH; Bao ED Mol Biol Rep; 2013 Mar; 40(3):2389-95. PubMed ID: 23184052 [TBL] [Abstract][Full Text] [Related]
10. TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis. Jiang DK; Yao L; Ren WH; Wang WZ; Peng B; Yu L Med Oncol; 2011 Dec; 28(4):1129-35. PubMed ID: 20552298 [TBL] [Abstract][Full Text] [Related]
11. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and risk of glioma. Zhang F; Li D; Li Y; Li H; Sun J; Li X; Li X Tumour Biol; 2014 Jan; 35(1):747-51. PubMed ID: 24046089 [TBL] [Abstract][Full Text] [Related]
12. Arg72Pro polymorphism of TP53 gene and the risk of skin cancer: a meta-analysis. Ye J; Li XF; Wang YD; Yuan Y PLoS One; 2013; 8(11):e79983. PubMed ID: 24260330 [TBL] [Abstract][Full Text] [Related]
13. No significant association between the TP53 codon 72 polymorphism and breast cancer risk: a meta-analysis of 21 studies involving 24,063 subjects. Ma Y; Yang J; Liu Z; Zhang P; Yang Z; Wang Y; Qin H Breast Cancer Res Treat; 2011 Jan; 125(1):201-5. PubMed ID: 20496166 [TBL] [Abstract][Full Text] [Related]
14. Meta-analysis demonstrates association between Arg72Pro polymorphism in the P53 gene and susceptibility to keloids in the Chinese population. Wu Y; Wang B; Li YH; Xu XG; Luo YJ; Chen JZ; Wei HC; Gao XH; Chen HD Genet Mol Res; 2012 Jun; 11(2):1701-11. PubMed ID: 22843046 [TBL] [Abstract][Full Text] [Related]
15. Updated meta-analysis of the TP53 Arg72Pro polymorphism and gastric cancer risk. Xiang B; Mi YY; Li TF; Liu PF Asian Pac J Cancer Prev; 2012; 13(5):1787-91. PubMed ID: 22901123 [TBL] [Abstract][Full Text] [Related]
16. Effect of TP53 Arg72Pro and MDM2 SNP309 polymorphisms on the risk of high-grade osteosarcoma development and survival. Toffoli G; Biason P; Russo A; De Mattia E; Cecchin E; Hattinger CM; Pasello M; Alberghini M; Ferrari C; Scotlandi K; Picci P; Serra M Clin Cancer Res; 2009 May; 15(10):3550-6. PubMed ID: 19451596 [TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of association between the TP53 Arg72Pro polymorphism and risk of endometriosis based on case-control studies. Yan Y; Wu R; Li S; He J Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():1-7. PubMed ID: 25819169 [TBL] [Abstract][Full Text] [Related]
18. P53 codon 72 polymorphism, human papillomavirus infection, and their interaction to oral carcinoma susceptibility. Hou J; Gu Y; Hou W; Wu S; Lou Y; Yang W; Zhu L; Hu Y; Sun M; Xue H BMC Genet; 2015 Jun; 16():72. PubMed ID: 26123760 [TBL] [Abstract][Full Text] [Related]
19. p.Arg72Pro polymorphism of P53 and breast cancer risk: a meta-analysis of case-control studies. Diakite B; Kassogue Y; Dolo G; Wang J; Neuschler E; Kassogue O; Keita ML; Traore CB; Kamate B; Dembele E; Nadifi S; Murphy RL; Doumbia S; Hou L; Maiga M BMC Med Genet; 2020 Oct; 21(1):206. PubMed ID: 33076844 [TBL] [Abstract][Full Text] [Related]
20. p53 Arg72Pro polymorphism confers the susceptibility to endometriosis among Asian and Caucasian populations. Lao X; Chen Z; Qin A Arch Gynecol Obstet; 2016 May; 293(5):1023-31. PubMed ID: 26493553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]